These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1365649)

  • 21. A double-blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Br J Clin Pharmacol; 1985; 19 Suppl 1(Suppl 1):37S-43S. PubMed ID: 2859877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cortico-subcortical electrophysiological study during the effects of benzodiazepines in patients with panic disorders].
    Guerrero Figueroa R; Heath RG; Escobar-Juyo A; Caballero-García G; Blanco-Castillo I
    Rev Neurol; 2001 Feb 16-28; 32(4):321-7. PubMed ID: 11333385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etizolam in the treatment of generalized anxiety disorder: a controlled clinical trial.
    Bertolino A; Mastucci E; Porro V; Corfiati L; Palermo M; Ecari U; Ceccarelli G
    J Int Med Res; 1989; 17(5):455-60. PubMed ID: 2572494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    Tesar GE
    J Clin Psychiatry; 1990 May; 51 Suppl():4-10; discussion 50-3. PubMed ID: 1970816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients.
    Davison K; Farquharson RG; Khan MC; Majid A
    Psychopharmacology (Berl); 1983; 80(4):308-10. PubMed ID: 6137856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G; Annable L; Fontaine R; Solyom L
    Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactate-induced anxiety after imipramine and diazepam treatment.
    Pohl R; Balon R; Berchou R; Lycaki H
    Anxiety; 1994; 1(2):54-63. PubMed ID: 9160549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.
    Jacobson AF; Goldstein BJ; Dominguez RA; Steinbook RM
    J Clin Psychiatry; 1983 Aug; 44(8):296-300. PubMed ID: 6135690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    Herman JB; Brotman AW; Rosenbaum JF
    J Clin Psychiatry; 1987 Oct; 48 Suppl():22-8. PubMed ID: 2889722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personality and benzodiazepine sensitivity in anxious patients and control subjects.
    Cowley DS; Roy-Byrne PP; Greenblatt DJ; Hommer DW
    Psychiatry Res; 1993 May; 47(2):151-62. PubMed ID: 8341768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo response in panic disorder.
    Coryell W; Noyes R
    Am J Psychiatry; 1988 Sep; 145(9):1138-40. PubMed ID: 3046384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.
    Ansseau M; Olié JP; von Frenckell R; Jourdain G; Stehle B; Guillet P
    Psychopharmacology (Berl); 1991; 104(4):439-43. PubMed ID: 1685793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alprazolam treatment for panic disorders.
    Alexander PE; Alexander DD
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder.
    Rimón R; Lepola U; Jolkkonen J; Halonen T; Riekkinen P
    Biol Psychiatry; 1995 Dec; 38(11):737-41. PubMed ID: 8580226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.